An investigation on behalf of investors in Aquestive Therapeutics, Inc. (NASDAQ:AQST) shares over potential wrongdoing at Aquestive Therapeutics, Inc. was announced.
San Diego, CA -- (SBWIRE) -- 09/29/2022 -- Certain directors of Aquestive Therapeutics, Inc. are under investigation on over potential breaches of fiduciary duties.
Investors who purchased shares of Aquestive Therapeutics, Inc. (NASDAQ: AQST) have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Aquestive Therapeutics, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.
On March 1, 2021, a lawsuit was filed against Aquestive Therapeutics, Inc. over alleged violations of Federal Securities Laws. The plaintiff claims that between December 2, 2019 and September 25, 2020, the Defendants made materially false and misleading statements regarding the Company's business, operational and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that data included in the Libervant NDA submission showed a lower drug exposure level than desired for certain weight groups, that the foregoing significantly decreased the Libervant NDA's approval prospects, that as a result, it was foreseeable that the FDA would not approve the Libervant NDA in its current form, and that as a result, the Company's public statements were materially false and misleading at all relevant times.
On June 25, 2021, an amended complaint was filed and on August 16, 2021, the defendants filed their motion to dismiss the case.
Those who purchased shares of Aquestive Therapeutics, Inc. (NASDAQ: AQST) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.